The US Food and Drug Administration has approved a vaccine against respiratory syncytial virus (RSV) – an illness that kills thousands of Americans each year.
The vaccine still needs approval from the US Centers for Disease Control and Prevention before it can be rolled out to the public.
Officials say the vaccine, named Arexvy by the manufacturer GSK, is a major breakthrough that will save many lives.
It could be available to people over 60 within months, officials say.
(BBC)
